Pep Grading
United StatesGHK-Cu and tissue repair
GHK-Cu has been investigated in experimental research for extracellular-matrix activity, fibroblast function, and tissue repair.
Klow Stack
KLOW is a research peptide blend containing GHK-Cu, BPC-157, TB-500, and KPV. Its individual components have been studied in preclinical research involving tissue repair, cellular signaling, and inflammatory pathways, but the complete blend has not been clinically validated.
Tissue RepairRecovery SupportAnti-Inflammatory ResearchWound Healing ResearchSkin & Hair Research
- Vendors
- 20 vendors
- Sizes
- 80 mg
- Intake
- Injections
Typical dose
No established human dose.
No established frequency
Route
No established human route
No established timing
Cycle
No established human cycle.
Typical duration
Storage
2–8°C
Follow vendor guidance
Marketplace
Vendor listings
20 offers for Klow Stack
| Vendor | Price | Rating | Shipping | COA | Action |
|---|---|---|---|---|---|
Renova Peptides
| $56.25 $0.70/mg | No reviews | 3–5 days United States | 1 file | |
Giga Compounds
| $60.00 $100.00 $0.75/mg −40% | No reviews | 2 days United States | 1 file | |
Amino Club
| $64.99 $99.99 $0.81/mg −35% | No reviews | 1–4 days United States | 1 file | |
idunpeptides
| $64.99 $0.81/mg | No reviews | 3–7 days United States, United Kingdom +1 | 1 file | |
Crownwell Research
| $69.99 $0.87/mg | No reviews | 1-5 days United States | 1 file | |
Reta One Labs
| $79.00 $0.99/mg | No reviews | 2 days United States | 1 file | |
Biologix Labs
| $97.99 $124.99 $1.22/mg −21.6% | No reviews | 2 Days United States, Canada | None | |
Bionova Peptides
| $99.00 $1.24/mg | No reviews | 1–3 days United States | 1 file |
What the research reports
Reported research benefits.
KLOW combines GHK-Cu, BPC-157, TB-500, and KPV. Research on the individual components suggests potential roles in tissue repair, wound healing, cellular signaling, and inflammatory pathways. The complete KLOW blend has not been clinically validated.
01
Tissue Repair
02
Wound Healing
03
Inflammatory Regulation
04
Cellular Signaling
Dosage and protocol
How it is typically studied.
No established human dosing protocol exists for the complete KLOW blend.
01 Route
No established human route
02 Example range
No established human dose
03 Frequency
No established frequency
04 Timing
No established timing
Educational reference only. Use clinician guidance for dosing decisions.
Evidence
What the studies actually show.
BPC-157 and wound healing
BPC-157 has demonstrated tissue-repair and wound-healing effects in several animal and laboratory models, but human clinical evidence remains limited.
Thymosin β4 and wound healing
Thymosin β4 has been studied for wound healing, cell migration, and tissue repair. TB-500 is related to thymosin β4 but should not automatically be considered equivalent.
KPV and inflammation
KPV has demonstrated anti-inflammatory effects through pathways involving NF-κB and MAPK in experimental models.
KLOW combination
No controlled PubMed clinical study has established the safety, efficacy, dose, or cycle of the complete KLOW combination.
Interactions
How it pairs with other peptides.
Other peptide therapies
No clinical interaction studies have established the safety of combining KLOW with other peptide therapies.
Anti-inflammatory drugs
KPV has demonstrated anti-inflammatory activity in experimental models; additive effects with anti-inflammatory drugs have not been clinically established.
Anticoagulants / antiplatelet drugs
No established human drug interaction with the complete KLOW blend has been reported in PubMed.
Copper supplements
GHK-Cu contains copper, but the clinical significance of combining KLOW with copper supplementation has not been established.
FAQ
Frequently asked questions.
No. KLOW is a research peptide combination and has not been clinically validated as a complete blend.